Works matching DE "MEROPENEM"
Results: 1519
Development and confirmation of humanized plasma and epithelial lining fluid exposures of meropenem, cefiderocol and tobramycin in a standardized neutropenic murine pneumonia model.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 478, doi. 10.1093/jac/dkae432
- By:
- Publication type:
- Article
Considerations for β-lactam antimicrobial continuous infusion. Authors' reply to Massart et al. and Marzaroli et al.
- Published in:
- 2025
- By:
- Publication type:
- Letter
Combining antibiotics with antivirulence compounds can have synergistic effects and reverse selection for antibiotic resistance in Pseudomonas aeruginosa.
- Published in:
- PLoS Biology, 2020, v. 18, n. 8, p. 1, doi. 10.1371/journal.pbio.3000805
- By:
- Publication type:
- Article
BACTERIAL PROFILES AND ANTIBIOTIC RESISTANCE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS WITH EXACERBATION AND TYPE 2 RESPIRATORY FAILURE AT ADAM MALIK GENERAL HOSPITAL.
- Published in:
- Folia Medica Indonesiana (2355-8393), 2024, v. 60, n. 3, p. 216, doi. 10.20473/fmi.v60i3.61441
- By:
- Publication type:
- Article
Stability and Validation of a High-Throughput LC-MS/MS Method for the Quantification of Cefepime, Meropenem, and Piperacillin and Tazobactam in Serum.
- Published in:
- Journal of Applied Laboratory Medicine, 2021, v. 6, n. 5, p. 1202, doi. 10.1093/jalm/jfab036
- By:
- Publication type:
- Article
INVESTIGATION OF VIRULENCE FACTORS AND ANTIBIOTIC RESISTANCE OF PSEUDOMONAS AERUGINOSA ISOLATED FROM A RANGE OF CLINICAL SAMPLES.
- Published in:
- Journal of Health Sciences of Kocaeli University / Kocaeli Üniversitesi Sağlık Bilimleri Dergisi, 2023, v. 9, n. 2, p. 137, doi. 10.30934/kusbed.1278999
- By:
- Publication type:
- Article
Bacteriological Study Of Chronic Suppurative Otitis Media.
- Published in:
- Diyala Journal of Medicine, 2020, v. 19, n. 1, p. 120, doi. 10.26505/DJM.19015680920
- By:
- Publication type:
- Article
Meropenem resistant Lactobacillus endocarditis in an immunocompetent patient.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Revisión sobre Meropenem/Vaborbactam en infecciones de piel y tejidos blandos por Bacilos Gram Negativos 2015-2023.
- Published in:
- Repertorio de Medicina y Cirugía, 2023, v. 32, p. 99, doi. 10.31260/RepertMedCir.01217372.1584
- By:
- Publication type:
- Article
Use of Simulation Strategies to Predict Subtherapeutic Meropenem Exposure Caused by Augmented Renal Clearance in Critically Ill Pediatric Patients With Sepsis.
- Published in:
- Journal of Pediatric Pharmacology & Therapeutics, 2020, v. 25, n. 5, p. 413, doi. 10.5863/1551-6776-25.5.413
- By:
- Publication type:
- Article
Synergistic effect of vancomycin combined with cefotaxime, imipenem, or meropenem against Staphylococcus aureus with reduced susceptibility to vancomycin.
- Published in:
- Turkish Journal of Medical Sciences, 2021, v. 51, n. 4, p. 2150, doi. 10.3906/sag-1910-166
- By:
- Publication type:
- Article
SARS-CoV-2 associated rhabdomyolysis in 32 patients.
- Published in:
- Turkish Journal of Medical Sciences, 2021, v. 51, n. 3, p. 1597, doi. 10.3906/sag-2012-327
- By:
- Publication type:
- Article
NEW EMERGING PATTERN OF SENSITIVITY OF SALMONELLA TYPHI: A SINGLE CENTER EXPERIENCE.
- Published in:
- Journal of Medical Sciences (1997-3438), 2024, v. 32, n. 2, p. 185, doi. 10.52764/jms.24.32.2.13
- By:
- Publication type:
- Article
THE EFFECTIVENESS OF CEFTRIAXONE AND MEROPENEM IN THE TREATMENT OF ENTERIC FEVER IN CHILDREN-EXPERIENCE IN A TERTIARY CARE HOSPITAL IN PAKISTAN.
- Published in:
- Journal of Medical Sciences (1997-3438), 2023, v. 31, n. 4, p. 320, doi. 10.52764/jms.23.31.4.13
- By:
- Publication type:
- Article
FREQUENCY AND ANTIMICROBIAL RESISTANCE PROFILE OF SALMONELLA TYPHI ISOLATED FROM DISTRICT BUNER.
- Published in:
- Journal of Medical Sciences (1997-3438), 2022, v. 30, n. 3, p. 185, doi. 10.52764/jms.22.30.3.5
- By:
- Publication type:
- Article
Pneumococcal meningitis in hyposplenism.
- Published in:
- Neurology & Clinical Neuroscience, 2017, v. 5, n. 1, p. 42, doi. 10.1111/ncn3.12090
- By:
- Publication type:
- Article
Investigation of In-Vitro Antibacterial Activity of Cotinus coggygria Scop. Extracts.
- Published in:
- Van Veterinary Journal, 2020, v. 31, n. 3, p. 127, doi. 10.36483/vanvetj.742535
- By:
- Publication type:
- Article
一例肺炎反复发作的重型颅脑损伤患者抗感染治疗策略分析.
- Published in:
- Pharmaceutial Care & Research, 2022, v. 22, n. 1, p. 69, doi. 10.5428/pcar20220114
- By:
- Publication type:
- Article
三种常用碳青霉烯类抗菌药物治疗急性胆道感染的疗效、安全性及药物经济学比较
- Published in:
- Pharmaceutial Care & Research, 2022, v. 22, n. 1, p. 39, doi. 10.5428/pcar20220108
- By:
- Publication type:
- Article
A case of complex multisite carbapenem-resistant Klebsiella pneumoniae infection and literature analysis.
- Published in:
- Pharmaceutial Care & Research, 2020, v. 20, n. 5, p. 371, doi. 10.5428/pcar20200512
- By:
- Publication type:
- Article
亚胺培南与美罗培南在临床应用中的对比分析.
- Published in:
- Pharmaceutial Care & Research, 2020, v. 20, n. 4, p. 299, doi. 10.5428/pcar20200414
- By:
- Publication type:
- Article
Establishment and application of drug screening model of Caenorhabditis elegans infected with drug resistant Acinetobacter baumannii.
- Published in:
- Pharmaceutial Care & Research, 2020, v. 20, n. 2, p. 107, doi. 10.5428/pcar20200207
- By:
- Publication type:
- Article
Antimicrobial Resistance in Sepsis Cases Due to Escherichia coli and Klebsiella pneumoniae : Pre-Pandemic Insights from a Single Center in Southwestern Romania.
- Published in:
- Healthcare (2227-9032), 2024, v. 12, n. 17, p. 1713, doi. 10.3390/healthcare12171713
- By:
- Publication type:
- Article
Rhodotorula mucilaginosa Fungemia in an Infected Biloma Patient Following a Traumatic Liver Injury.
- Published in:
- Healthcare (2227-9032), 2024, v. 12, n. 9, p. 880, doi. 10.3390/healthcare12090880
- By:
- Publication type:
- Article
A COVID Dilemma: How to Manage Pregnancies in Case of Severe Respiratory Failure?
- Published in:
- Healthcare (2227-9032), 2023, v. 11, n. 4, p. 486, doi. 10.3390/healthcare11040486
- By:
- Publication type:
- Article
大肠埃希菌泌尿系统感染患者临床分布及药物敏感性分析.
- Published in:
- Progress in Modern Biomedicine, 2021, v. 21, n. 14, p. 2721, doi. 10.13241/j.cnki.pmb.2021.14.026
- By:
- Publication type:
- Article
大肠埃希菌泌尿系统感染患者临床分布及药物敏感性分析.
- Published in:
- Progress in Modern Biomedicine, 2021, n. 13, p. 2721, doi. 10.13241/j.cnki.pmb.2021.14.026
- By:
- Publication type:
- Article
头孢哌酮舒巴坦联合美罗培南对重症肺炎患者动脉血气指标及血清 TNF-α、PCT、CRP 水平的影响.
- Published in:
- Progress in Modern Biomedicine, 2021, n. 13, p. 2547, doi. 10.13241/j.cnki.pmb.2021.13.031
- By:
- Publication type:
- Article
呼吸机辅助美罗培南及胸腺法新治疗重症肺炎的疗效及对患者 血清炎症因子水平的影响*.
- Published in:
- Progress in Modern Biomedicine, 2020, v. 20, n. 21, p. 4113, doi. 10.13241/j.cnki.pmb.2020.21.025
- By:
- Publication type:
- Article
Prevalence and antimicrobial resistance of Enterobacteriaceae in the north of Kazakhstan.
- Published in:
- Open Veterinary Journal, 2024, v. 14, n. 2, p. 604, doi. 10.5455/OVJ.2024.v14.i2.1
- By:
- Publication type:
- Article
Fabrication and antimicrobial properties of novel meropenem‐honey encapsulated chitosan nanoparticles against multiresistant and biofilm‐forming Staphylococcus aureus as a new antimicrobial agent.
- Published in:
- Veterinary Medicine & Science, 2024, v. 10, n. 3, p. 1, doi. 10.1002/vms3.1440
- By:
- Publication type:
- Article
In-vitro activity of newly-developed β-lactamase inhibitors avibactam, relebactam and vaborbactam in combination with anti-pseudomonal β-lactam antibiotics against AmpC-overproducing clinical Pseudomonas aeruginosa isolates.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2025, v. 44, n. 2, p. 277, doi. 10.1007/s10096-024-04965-x
- By:
- Publication type:
- Article
Evaluation of EUCAST rapid antimicrobial susceptibility test directly from positive blood culture for Pseudomonas aeruginosa.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2024, v. 43, n. 10, p. 2061, doi. 10.1007/s10096-024-04895-8
- By:
- Publication type:
- Article
Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa collected in Greece and Italy—SMART 2017–2021.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2024, v. 43, n. 7, p. 1343, doi. 10.1007/s10096-024-04756-4
- By:
- Publication type:
- Article
Multidrug-resistant Gram-negative clinical isolates with reduced susceptibility/resistance to cefiderocol: which are the best present and future therapeutic alternatives?
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2024, v. 43, n. 2, p. 339, doi. 10.1007/s10096-023-04732-4
- By:
- Publication type:
- Article
Assessing the colony morphotypes and antibiotic susceptibility profile of Malaysian clinical Burkholderia pseudomallei to support the use of EUCAST disk diffusion breakpoints to determine antibiotic resistance.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2024, v. 43, n. 2, p. 373, doi. 10.1007/s10096-023-04707-5
- By:
- Publication type:
- Article
Evaluation of the ceftazidime/avibactam and meropenem susceptibility by MALDI-TOF MS directly from positive blood cultures.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2024, v. 43, n. 1, p. 171, doi. 10.1007/s10096-023-04696-5
- By:
- Publication type:
- Article
Ertapenem plus meropenem combination treatment in carbapenem-resistant Klebsiella pneumoniae bacteremia: an analysis of 53 cases.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2023, v. 42, n. 10, p. 1269, doi. 10.1007/s10096-023-04660-3
- By:
- Publication type:
- Article
Efficacy of ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam combinations against carbapenemase-producing Enterobacterales in Switzerland.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2023, v. 42, n. 9, p. 1145, doi. 10.1007/s10096-023-04647-0
- By:
- Publication type:
- Article
Antimicrobial activity of ceftibuten-avibactam against a global collection of Enterobacterales from patients with urinary tract infections (2021).
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2023, v. 42, n. 4, p. 453, doi. 10.1007/s10096-023-04562-4
- By:
- Publication type:
- Article
Evaluation of the Reveal® rapid AST system to assess the susceptibility of Pseudomonas aeruginosa from blood cultures.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2023, v. 42, n. 3, p. 359, doi. 10.1007/s10096-023-04556-2
- By:
- Publication type:
- Article
Reduction of antibiotic use and multi-drug resistance bacteria infection in neonates after improvement of antibiotics use strategy in a level 4 neonatal intensive care unit in southern China.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2023, v. 42, n. 1, p. 87, doi. 10.1007/s10096-022-04522-4
- By:
- Publication type:
- Article
In vitro and in vivo efficacy of cefiderocol plus tigecycline, colistin, or meropenem against carbapenem-resistant Acinetobacter baumannii.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2022, v. 41, n. 12, p. 1451, doi. 10.1007/s10096-022-04503-7
- By:
- Publication type:
- Article
Inoculum effect of Enterobacterales co-expressing OXA-48 and CTX-M on the susceptibility to ceftazidime/avibactam and meropenem.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2022, v. 41, n. 5, p. 853, doi. 10.1007/s10096-022-04430-7
- By:
- Publication type:
- Article
Evaluation of the VITEK2 AST-XN17 card for the detection of carbapenemase-producing Enterobacterales in isolates primarily producing metallo β-lactamase.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2022, v. 41, n. 5, p. 723, doi. 10.1007/s10096-022-04424-5
- By:
- Publication type:
- Article
Fosfomycin as a salvage therapy for treating urinary tract infections due to multidrug-resistant Escherichiacoli.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2022, v. 41, n. 4, p. 689, doi. 10.1007/s10096-022-04412-9
- By:
- Publication type:
- Article
Occurrence of multi-carbapenemases producers among carbapenemase-producing Enterobacterales and in vitro activity of combinations including cefiderocol, ceftazidime-avibactam, meropenem-vaborbactam, and aztreonam in the COVID-19 era.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2022, v. 41, n. 4, p. 573, doi. 10.1007/s10096-022-04408-5
- By:
- Publication type:
- Article
Iron serum levels and iron homeostasis parameters in patients with nosocomial pneumonia treated with cefiderocol: post hoc analysis of the APEKS-NP study.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2022, v. 41, n. 3, p. 467, doi. 10.1007/s10096-021-04399-9
- By:
- Publication type:
- Article
Interplay between Klebsiella pneumoniae producing KPC-31 and KPC-3 under treatment with high dosage meropenem: a case report.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2022, v. 41, n. 3, p. 495, doi. 10.1007/s10096-021-04388-y
- By:
- Publication type:
- Article
Comparative activity of newer β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa from patients hospitalized with pneumonia in European medical centers in 2020.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2022, v. 41, n. 2, p. 319, doi. 10.1007/s10096-021-04363-7
- By:
- Publication type:
- Article